Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-03153-6.pdf
Reference40 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87–108, doi: 10.3322/caac.21262 (2015).
2. Li, D., Xie, K., Wolff, R. & Abbruzzese, J. L. Pancreatic cancer. Lancet (London, England) 363, 1049–1057, doi: 10.1016/s0140-6736(04)15841-8 (2004).
3. Heinemann, V., Haas, M. & Boeck, S. Systemic treatment of advanced pancreatic cancer. Cancer treatment reviews 38, 843–853, doi: 10.1016/j.ctrv.2011.12.004 (2012).
4. Crusz, S. M. & Balkwill, F. R. Inflammation and cancer: advances and new agents. Nature reviews. Clinical oncology 12, 584–596, doi: 10.1038/nrclinonc.2015.105 (2015).
5. Pine, J. K. et al. Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 35, 605–610, doi: 10.1016/j.ejso.2008.12.002 (2009).
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between the C-reactive protein to albumin ratio with asthma and mortality in adult: a population-based study;Scientific Reports;2024-09-04
2. Novel Somay’s GLUCAR Index Efficiently Predicts Survival Outcomes in Locally Advanced Pancreas Cancer Patients Receiving Definitive Chemoradiotherapy: A Propensity-Score-Matched Cohort Analysis;Journal of Personalized Medicine;2024-07-13
3. Albumin plus CEA: a novel biomarker for predicting prognosis in resectable gastric cancer: a case-control study;2024-05-15
4. Predictors of elevated C-reactive protein among pre-treatment, newly diagnosed breast cancer patients: A cross-sectional study;Cancer Treatment and Research Communications;2024
5. Systemic inflammation adversely affects response to anamorelin in patients with pancreatic cancer;Supportive Care in Cancer;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3